Schilling et al., 2010 - Google Patents
Influence of plasticizer type and level on the properties of Eudragit® S100 matrix pellets prepared by hot-melt extrusionSchilling et al., 2010
- Document ID
- 219224610938879543
- Author
- Schilling S
- Lirola H
- Shah N
- Waseem Malick A
- McGinity J
- Publication year
- Publication venue
- Journal of microencapsulation
External Links
Snippet
Matrix-type pellets with controlled-release properties may be prepared by hot-melt extrusion applying a single-step, continuous process. However, the manufacture of gastric-resistant pellets is challenging due to the high glass transition temperature of most enteric polymers …
- 239000008188 pellet 0 title abstract description 127
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schilling et al. | Influence of plasticizer type and level on the properties of Eudragit® S100 matrix pellets prepared by hot-melt extrusion | |
| Crowley et al. | Pharmaceutical applications of hot-melt extrusion: part I | |
| Lang et al. | Hot-melt extrusion–basic principles and pharmaceutical applications | |
| Zhu et al. | Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers | |
| Ma et al. | Applications of poly (ethylene oxide) in controlled release tablet systems: a review | |
| Repka et al. | Melt extrusion: process to product | |
| Jijun et al. | Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion | |
| Repka et al. | Applications of hot-melt extrusion for drug delivery | |
| Çelik | Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation | |
| Feng et al. | Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion | |
| Palem et al. | Oral transmucosal delivery of domperidone from immediate release films produced via hot-melt extrusion technology | |
| Alsulays et al. | Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole | |
| Deng et al. | Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion | |
| Schilling et al. | Properties of melt extruded enteric matrix pellets | |
| Alshetaili et al. | Development and characterization of sustained-released donepezil hydrochloride solid dispersions using hot melt extrusion technology | |
| Dalziel et al. | Assessment of granulation technologies for an API with poor physical properties | |
| A. Ashour et al. | Influence of pressurized carbon dioxide on ketoprofen-incorporated hot-melt extruded low molecular weight hydroxypropylcellulose | |
| Kulkarni et al. | Application of hot melt extrusion for improving bioavailability of artemisinin a thermolabile drug | |
| Yang et al. | Preparation and evaluation of metoprolol tartrate sustained-release pellets using hot melt extrusion combined with hot melt coating | |
| Alam et al. | Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability | |
| El-Bary et al. | Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an in vitro/in silico study | |
| Essa et al. | Controlled precipitation for enhanced dissolution rate of flurbiprofen: Development of rapidly disintegrating tablets | |
| Moin et al. | Modulation of drug release from natural polymer matrices by response surface methodology: In vitro and in vivo evaluation | |
| Andrews et al. | Hot-melt extrusion: an emerging drug delivery technology. | |
| Yan et al. | Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion/spheronization and an investigation of their stability |